Results 121 to 130 of about 55,552 (271)
Development and biological evaluation of Iinkjet printed drug coatings on intravascular stent [PDF]
Inkjet–printing technology was used to apply biodegradable and biocompatible polymeric coatings of poly(D, L lactide) with the antiproliferative drugs simvastatin (SMV) and paclitaxel (PCX) on coronary metal stents.
Blanchemain, Nicolas +9 more
core +1 more source
Vancomycin‐Functionalized Nanodelivery Systems for Antibacterial Tissue Engineering Scaffolds
This review consolidates recent advancements in VAN nanoformulations, critically evaluating their design principles, release mechanisms, and efficacy profiles against resistant Gram‐positive pathogens. While promising in vitro and in vivo results have been demonstrated, the clinicaltranslation of these technologies necessitates further rigorous ...
Nima Beheshtizadeh +5 more
wiley +1 more source
Clinical Outcomes of Drug-Eluting Balloon for In-Stent Restenosis Based on the Number of Metallic Layers [PDF]
Hiroto Yabushita +19 more
openalex +1 more source
Graphical summary of postpartum SCAD: (A) ECG with ST‐elevation; (B) surgical revascularization with BIMA and saphenous vein grafts; (C–D) coronary angiography showing RCA and LAD dissection; (E–F) intraoperative subepicardial hematoma of LM and LCx. ABSTRACT This case report details a rare instance of recurrent spontaneous coronary artery dissection ...
Lorenzo Giovannico +7 more
wiley +1 more source
Drug-eluting stents are a commonly used treatment for coronary artery disease. However, the coatings used in drug-eluting stents have some limitations such as poor biocompatibility and drug loading capacity.
Feng Zhao +14 more
doaj +1 more source
Percutaneous Coronary Interventions in Stable and Acute Coronary Syndromes: Stent technology, lesion complexity and clinical outcome [PDF]
__Abstract__ Percutaneous coronary intervention (PCI) has brought a major revolution in the way we manage coronary artery disease. Since the first intervention by Andreas Grüntzig in 1977, development of the technology has been relentless and today ...
Magro, M. (Michael)
core
Zilver PTX RCT mortality analysis: no difference in long-term mortality rate for Zilver PTX drug-eluting stent compared to PTA/BMS [PDF]
Michael D. Dake +2 more
openalex +1 more source
Biodegradable polymer everolimus-eluting stents versus contemporary drug-eluting stents: a systematic review and meta‑analysis [PDF]
Juntao Yin +4 more
openalex +1 more source
PASSIVATE‐CAP Research Overview and Flowchart. ABSTRACT Background Patients with acute coronary syndrome (ACS) face a significantly increased risk of cardiovascular events due to vulnerable plaques. However, no clear evidence supports performing preventive percutaneous coronary intervention (PCI) for non‐flow‐limiting vulnerable plaques.
Zhongxiu Chen +11 more
wiley +1 more source
The effect of age on improvement in health‐related quality of life (HRQoL) after percutaneous coronary intervention (PCI)—Do older adults benefit from PCI equally to their younger peers in respect of HRQoL and symptom relief? ABSTRACT Introduction Percutaneous coronary intervention (PCI) is the first‐line therapy in patients scheduled for coronary ...
Laura Lappalainen +6 more
wiley +1 more source

